NASDAQ : NPCE

NeuroPace, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 13.01 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 446.56M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

NeuroPace, Inc. (NPCE) reported revenue of 106.99M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue106.99M99.99M79.91M65.42M45.52M45.18M
Cost of Revenue24.20M22.77M20.82M17.30M13.03M11.75M
Gross Profit82.79M77.22M59.09M48.12M32.49M33.44M
Selling, General & Admin67.24M65.67M57.10M54.52M51.34M38.96M
Research & Development27.69M27.89M23.65M20.78M21.95M18.21M
Operating Expenses94.93M93.56M80.76M75.30M73.29M57.17M
Operating Income-12.14M-16.34M-21.67M-27.17M-40.79M-23.74M
Interest Expense-6.30M-7.46M-8.80M-8.52M-7.53M-7.41M
Interest & Investment Income2.39M2.82M3.02M3.05M1.58M448.00K
Other Non Operating Income (Expenses)335.00K-27.00K75.00K19.00K-5.38M
EBT Excluding Unusual Items-15.71M-21.01M-27.37M-32.64M-46.73M-36.08M
Gain (Loss) on Sale of Investments41.00K41.00K229.00K-315.00K-356.00K
Other Unusual Items-500.00K-500.00K
Pretax Income-16.17M-21.46M-27.14M-32.96M-47.08M-36.08M
Net Income-19.11M-21.46M-27.14M-32.96M-47.08M-36.08M
Net Income to Common-19.11M-21.46M-27.14M-32.96M-47.08M-36.08M
Shares Outstanding (Basic)33.59M32.72M29.13M25.85M24.59M16.61M
Shares Outstanding (Diluted)33.59M32.72M29.13M25.85M24.59M16.61M
EPS (Basic)-0.57-0.66-0.93-1.27-1.91-2.17
EPS (Diluted)-0.57-0.66-0.93-1.27-1.91-2.17
Free Cash Flow-11.61M-11.34M-18.25M-19.87M-37.47M-24.96M
Free Cash Flow Per Share-0.35-0.35-0.63-0.77-1.52-1.50
Gross Margin77.38%77.23%73.94%73.56%71.38%74.00%
Operating Margin-11.34%-16.34%-27.12%-41.54%-89.62%-52.53%
Profit Margin-17.87%-21.47%-33.97%-50.38%-103.43%-79.85%
Free Cash Flow Margin-10.85%-11.34%-22.85%-30.38%-82.32%-55.24%
EBITDA-11.88M-16.10M-21.46M-27.00M-40.53M-23.44M
EBITDA Margin-11.10%-16.10%-26.86%-41.27%-89.03%-51.88%
D&A For EBITDA260.00K238.00K207.00K172.00K267.00K296.00K
EBIT-12.14M-16.34M-21.67M-27.17M-40.79M-23.74M
EBIT Margin-11.34%-16.34%-27.12%-41.54%-89.62%-52.53%
Advertising Expenses500.00K700.00K700.00K700.00K100.00K

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents12.54M21.69M13.43M18.06M6.61M19.19M
Short-Term Investments39.16M39.37M39.33M48.40M70.80M96.40M
Cash & Short-Term Investments51.70M61.06M52.76M66.45M77.41M115.58M
Receivables14.93M14.68M12.85M12.31M7.48M7.09M
Inventory18.11M16.90M13.38M11.21M9.71M7.82M
Prepaid Expenses1.45M1.44M2.35M2.74M3.11M2.22M
Other Current Assets100.00K
Total Current Assets86.19M94.07M81.34M92.72M97.71M132.82M
Property, Plant & Equipment10.46M11.26M12.89M14.41M15.90M603.00K
Long-Term Deferred Charges276.00K387.00K347.00K
Other Long-Term Assets339.00K235.00K137.00K137.00K143.00K143.00K
Total Assets96.99M105.56M94.65M107.65M114.11M133.56M
Accounts Payable4.20M2.22M2.95M2.33M2.15M1.38M
Accrued Expenses10.85M13.34M9.79M11.18M7.41M7.43M
Current Portion of Leases2.26M2.12M1.86M1.63M1.42M
Current Unearned Revenue123.00K141.00K555.00K1.09M
Other Current Liabilities490.00K
Total Current Liabilities17.43M17.81M15.16M16.23M10.98M9.30M
Long-Term Debt59.01M58.88M59.52M56.95M52.91M49.85M
Long-Term Leases8.66M9.84M11.95M13.81M15.44M
Other Long-Term Liabilities911.00K
Total Liabilities85.11M86.53M86.63M87.00M79.33M60.06M
Common Stock34.00K34.00K30.00K28.00K25.00K24.00K
Additional Paid-In Capital577.15M571.41M538.93M524.43M506.71M497.52M
Retained Earnings-565.30M-552.41M-530.95M-503.81M-470.85M-423.77M
Comprehensive Income & Other-1.11M-272.00K
Total Common Equity11.88M19.03M8.01M20.65M34.78M73.50M
Shareholders' Equity11.88M19.03M8.01M20.65M34.78M73.50M
Total Liabilities & Equity96.99M105.56M94.65M107.65M114.11M133.56M
Total Debt69.93M70.84M73.34M72.39M69.77M49.85M
Net Cash (Debt)-18.23M-9.78M-20.58M-5.94M7.64M65.74M
Net Cash Per Share-0.54-0.30-0.71-0.230.313.96
Filing Date Shares Outstanding34.32M33.67M32.56M28.34M25.10M24.47M
Total Common Shares Outstanding34.28M33.57M30.15M27.82M25.05M24.45M
Working Capital68.76M76.26M66.18M76.49M86.74M123.52M
Book Value Per Share0.350.570.270.741.393.01
Tangible Book Value11.88M19.03M8.01M20.65M34.78M73.50M
Tangible Book Value Per Share0.350.570.270.741.393.01
Machinery7.14M6.90M6.59M6.34M7.39M6.66M
Leasehold Improvements2.44M2.44M2.44M2.43M2.40M2.40M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-19.11M-21.46M-27.14M-32.96M-47.08M-36.08M
Depreciation & Amortization2.05M1.95M1.77M1.60M2.99M296.00K
Other Amortization271.00K237.00K228.00K283.00K258.00K267.00K
Loss (Gain) From Sale of Assets12.00K14.00K
Loss (Gain) From Sale of Investments124.00K-41.00K-229.00K315.00K356.00K
Stock-Based Compensation9.82M11.09M10.28M9.56M8.35M4.29M
Other Operating Activities515.00K1.22M2.59M3.98M3.05M6.28M
Change in Accounts Receivable-1.38M-1.83M-536.00K-4.85M-391.00K1.30M
Change in Inventory-1.98M-3.67M-2.42M-1.70M-2.13M-1.16M
Change in Accounts Payable-450.00K-730.00K671.00K240.00K647.00K479.00K
Change in Unearned Revenue-573.00K-414.00K-534.00K1.09M
Change in Other Net Operating Assets-544.00K2.63M-2.63M2.73M-2.91M-259.00K
Operating Cash Flow-11.24M-11.01M-17.95M-19.70M-36.87M-24.58M
Capital Expenditures-369.00K-332.00K-306.00K-173.00K-603.00K-384.00K
Investment in Securities9.30M23.20M24.40M-85.01M
Investing Cash Flow-369.00K-332.00K8.99M23.03M23.80M-85.40M
Long-Term Debt Issued58.44M
Total Debt Issued-133.00K58.44M
Long-Term Debt Repaid-60.51M-4.09M
Net Debt Issued (Repaid)-133.00K-2.07M-4.09M
Issuance of Common Stock2.06M71.76M5.21M8.69M896.00K110.01M
Repurchase of Common Stock-368.00K-50.09M-881.00K-259.00K-59.00K
Other Financing Activities-150.00K-305.00K-347.00K-3.39M
Financing Cash Flow1.41M19.60M4.33M8.13M490.00K102.53M
Net Cash Flow-10.20M8.26M-4.63M11.45M-12.58M-7.45M
Free Cash Flow-11.61M-11.34M-18.25M-19.87M-37.47M-24.96M
Free Cash Flow Margin-10.85%-11.34%-22.85%-30.38%-82.32%-55.24%
Free Cash Flow Per Share-0.35-0.35-0.63-0.77-1.52-1.50
Levered Free Cash Flow-2.63M-3.96M-10.70M-11.95M-22.02M-14.00M
Unlevered Free Cash Flow1.04M463.75K-5.42M-6.91M-17.58M-9.64M
Cash Interest Paid5.71M6.20M6.23M4.48M4.46M6.34M
Change in Working Capital-4.92M-4.01M-5.45M-2.48M-4.79M368.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization428.02M514.27M334.00M270.98M37.11M245.09M
Enterprise Value446.26M525.44M350.67M281.33M20.03M171.33M
Last Close Price12.3015.4411.1910.311.4910.08
PS Ratio4.075.144.184.140.815.42
PB Ratio35.4927.0241.6813.121.073.33
P/TBV Ratio36.6627.0241.6813.121.073.33
EV/Sales Ratio4.245.254.394.300.443.79
Debt / Equity Ratio5.883.729.153.502.010.68
Net Debt / Equity Ratio1.530.512.570.29-0.22-0.89
Net Debt / EBITDA Ratio-1.53-0.61-0.96-0.220.192.80
Net Debt / FCF Ratio-1.57-0.86-1.13-0.300.202.63
Asset Turnover1.051.000.790.590.370.48
Inventory Turnover1.411.501.691.651.491.59
Quick Ratio3.824.254.334.857.7313.19
Current Ratio4.945.285.375.718.9014.28
Return on Equity (ROE)-103.27%-158.74%-189.35%-118.91%-86.96%-106.96%
Return on Assets (ROA)-7.47%-10.20%-13.39%-15.32%-20.59%-15.66%
Return on Capital Employed (ROCE)-15.30%-18.60%-27.30%-29.70%-39.60%-19.10%
Earnings Yield-4.56%-4.17%-8.13%-12.16%-126.89%-14.72%
FCF Yield-2.67%-2.21%-5.47%-7.33%-100.99%-10.18%
Buyback Yield / Dilution-8.60%-12.35%-12.67%-5.11%-48.08%-8,038.86%